| Ms Jacqueline Sue Adams, ST | |
|
2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017-3912 | |
| (859) 426-5666 | |
| (859) 426-5665 |
| Full Name | Ms Jacqueline Sue Adams |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2865 Chancellor Dr, Crestview Hills, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396881736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | KY2628 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jacqueline Sue Adams, ST 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017-3912 Ph: (859) 426-5666 | Ms Jacqueline Sue Adams, ST 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017-3912 Ph: (859) 426-5666 |
News Archive
The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen Brandeis University Professor Derek M. Isaacowitz, as the 2009 recipient of the Margret M. & Paul B. Baltes Foundation Award in Behavioral and Social Gerontology.
Medivir had a very satisfactory 2009. Our cold sore product secured market approval in the US and Europe and is well positioned for launch. This will take place under the XerclearTM trademark in Europe, and under the XereseTM trademark in the US during 2010.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
Every school should have its own school nurse, based on site, to help tackle child obesity, nutritional problems and teenage pregnancy, according to new research from the Fabian Society.
Shire plc, the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.
› Verified 6 days ago
Crista Yeager, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 859-426-5666 | |
Ms. Stephanie Bright, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr Ste 105, Crestview Hills, KY 41017 Phone: 859-426-5666 | |
Lauren Elizabeth Ford, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Crestview Hills, KY 41017 Phone: 859-426-5666 | |
Janet Dea Hackett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 859-426-5666 Fax: 859-426-5665 | |
Ms. Leigha Brooke Ochsner, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Thomas More Pkwy Ste 102, Crestview Hills, KY 41017 Phone: 859-426-5666 | |
Mrs. Debra Lynn Way, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2865 Chancellor Dr, Suite 105, Crestview Hills, KY 41017 Phone: 856-426-5666 Fax: 856-426-5665 |